Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
* To determine the activity and efficacy of the schema specified as dose regimen
* To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU
Esophageal Neoplasms
DRUG: Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)
Efficacy endpoints include tumor response, progression free and overall survival., Throughout the whole study
Safety endpoints include summary of adverse events assessed by history, physical exams and laboratory evaluations., Throughout the whole study duration
* To determine the activity and efficacy of the schema specified as dose regimen
* To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU